Point72 Hong Kong’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Point72 Hong Kong’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-107,592	Closed	-$10.3M	–	1541
2019 Q2	$10.3M	Sell	107,592 -8,347	-7%	-$786K	2.81%	6
2019 Q1	$10.6M	Buy	115,939 +42,069	+57%	+$3.44M	4.17%	4
2018 Q4	$5.61M	Buy	73,870 +26,574	+56%	+$1.96M	2.62%	10
2018 Q3	$3.78M	Sell	47,296 -56,501	-54%	-$5.26M	1.29%	20
2018 Q2	$10.3M	Buy	+103,797	New	+$8.97M	3.49%	6
2016 Q4	–	Sell	-31,500	Closed	-$3.92M	–	1138
2016 Q3	$3.92M	Buy	+31,500	New	+$3.72M	2.14%	3
2014 Q3	–	Sell	-48,815	Closed	-$2.17M	–	517
2014 Q2	$2.17M	Buy	+48,815	New	+$1.99M	7.72%	6

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Point72 Hong Kong's CBPO Position: Q3 2019 in Review

Point72 Hong Kong sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2019, closing a stake of 107,592 shares — an estimated $10.3M sold.

Point72 Hong Kong first reported a position in CBPO in Q2 2014 and held it in 7 quarters. The position peaked at $10.6M in Q1 2019. 88 funds tracked by Wall St. Rank hold CBPO as of Q3 2019.

Point72 Hong Kong reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2019 after selling out during the quarter.
Point72 Hong Kong sold 107,592 China Biologic Products Holdings, Inc. shares in Q3 2019, an estimated $10.3M.
Point72 Hong Kong first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 7 quarters.
Point72 Hong Kong's China Biologic Products Holdings, Inc. position peaked at $10.6M in Q1 2019.
88 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2019.

Based on Point72 Hong Kong's 13F filing for Q3 2019, filed 14 Nov 2019.